Akero Therapeutics Inc Stock
Price
Target price
€19.52
€19.52
0.440%
0.085
0.440%
€38.19
22.04.24 / Tradegate
WKN: A2PLNP / Symbol: AKRO / Name: Akero Therapeutics / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Akero Therapeutics Inc Stock
The Akero Therapeutics Inc stock is trending slightly upwards today, with an increase of €0.085 (0.440%) compared to yesterday's price.
With 12 Buy predictions and not the single Sell prediction the community is currently very high on Akero Therapeutics Inc.
With a target price of 38 € there is a hugely positive potential of 94.72% for Akero Therapeutics Inc compared to the current price of 19.52 €.
Our community identified positive and negative aspects for Akero Therapeutics Inc stock for the coming years. 2 users see the criterium "Revenue growth" as a plus for the Akero Therapeutics Inc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Akero Therapeutics Inc in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Akero Therapeutics Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Akero Therapeutics Inc | 0.440% | -4.197% | -18.004% | -49.962% | -10.482% | - | - |
| Ardelyx Inc. | 0.130% | -4.466% | -13.831% | 35.956% | 5.848% | -10.686% | - |
| Salarius Pharmaceuticals Inc. | 0.950% | -2.778% | -19.231% | -68.421% | -24.324% | -98.250% | -99.994% |
| Brainstorm Cell | 1.170% | -0.586% | 0.792% | -81.287% | 119.397% | -80.271% | - |
Comments
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its price target raised by analysts at UBS Group AG from $39.00 to $42.00. They now have a "buy" rating on the stock.
Show more
Ratings data for AKRO provided by MarketBeat
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its price target raised by analysts at HC Wainwright from $40.00 to $43.00. They now have a "buy" rating on the stock.
Show more
Ratings data for AKRO provided by MarketBeat
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
Show more
Ratings data for AKRO provided by MarketBeat